Cancer treatment in the past has been based on contemporary biologic u
nderstanding of the disease process. For most of this century cancer w
as viewed as an anatomic problem, and the treatment was surgical, with
radical and extended radical operations viewed as appropriate. With i
mproved understanding of the true biologic nature of cancer, the exten
t of surgery has been modified, and clinical trials have confirmed the
suitability of breast-conserving surgery. At the same time, adjuvant
chemotherapies have extended disease-free survival and survival for ma
ny categories of patient. Unfortunately, these gains have been of limi
ted clinical dimensions. More recently, the genetic model of cancer ha
s led to attempts at cancer prevention. In the biologic sense we have
entered an era in which surgery is the adjuvant therapy, and systemic
treatments have increased breast cancer cure rates. We must now move f
rom a strategy that tries to kill cancer cells to one that seeks to co
ntrol their growth, which may, if successful provide an approach for t
rue cancer prevention.